News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Can't Afford GlaxoSmithKline (GSK)



8/6/2014 7:33:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

There is speculation that with Pfizer's (NYSE:PFE) bid for AstraZeneca (NYSE:AZN) off the table for now, Pfizer is considering other large pharmaceutical companies to pursue such as GlaxoSmithKline (NYSE:GSK). In a previous article, I discussed that Pfizer needs to acquire a promising drug pipeline, such as the one AstraZeneca holds, to fuel future growth. Synergies with the acquired company in Pfizer's current areas of expertise would also allow it to offer shareholders more value once it spins off non-core assets like its generic drug business.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES